Target
CD4 T cells
2 abstracts
Abstract
CD4 effector T cell expansion to identify objective responses to the CD40 agonist mitazalimab in combination with modified FOLFIRINOX (mFFX) as first-line therapy for metastatic pancreatic ductal adenocarcinoma (mPDAC) in the OPTIMIZE-1 study.Org: Hospital of the University of Pennsylvania, Alligator Bioscience,
Abstract
The efficacy of recombinant human adenovirus type 5 (H101) intra-tumor therapy in persistent/recurrent/metastatic gynecological cancer and the exploration of changes in tumor microenvironment.Org: The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China,